Yuzhen Ouyang

87 Xiangya Road
Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Correction: Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects.

Correction: Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects.

Journal: Molecular cancer
Published: May 01, 2026

Efgartigimod Versus Lymphoplasmapheresis as Preoperative Rapid Antibody-Clearing Therapies for Thymectomy in Generalized Myasthenia Gravis: Effectiveness, Safety and Cost Outcomes Compared to Conventional Preparation.

Efgartigimod Versus Lymphoplasmapheresis as Preoperative Rapid Antibody-Clearing Therapies for Thymectomy in Generalized Myasthenia Gravis: Effectiveness, Safety and Cost Outcomes Compared to Conventional Preparation.

Journal: CNS neuroscience & therapeutics
Published: November 09, 2025

T cell exhaustion: next-generation target of autoimmune diseases?

T cell exhaustion: next-generation target of autoimmune diseases?

Journal: Journal of leukocyte biology
Published: October 24, 2025

Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects.

Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects.

Journal: Molecular cancer
Published: September 28, 2025

Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects.

Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects.

Journal: Molecular cancer
Published: September 28, 2025

Antibody glycosylation in neuroimmune diseases.

Antibody glycosylation in neuroimmune diseases.

Journal: Journal of translational medicine
Published: September 18, 2025

HLA-A*11:01 and HLA-C*03 Binding to FKBP1A Influences the Efficacy of Tacrolimus in Myasthenia Gravis Subgroups.

HLA-A*11:01 and HLA-C*03 Binding to FKBP1A Influences the Efficacy of Tacrolimus in Myasthenia Gravis Subgroups.

Journal: HLA
Published: August 25, 2025

Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study.

Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study.

Journal: Therapeutic advances in neurological disorders
Published: August 09, 2025

Circulating inflammatory proteins as pathogenic mediators and potential therapeutic targets in myasthenia gravis.

Circulating inflammatory proteins as pathogenic mediators and potential therapeutic targets in myasthenia gravis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: March 25, 2025

Regulatory Roles of SWI/SNF Chromatin Remodeling Complexes in Immune Response and Inflammatory Diseases.

Regulatory Roles of SWI/SNF Chromatin Remodeling Complexes in Immune Response and Inflammatory Diseases.

Journal: Clinical reviews in allergy & immunology
Published: December 13, 2024

Muscle-driven spinal cord histological and transcriptomic alterations in a myotonic dystrophy mouse model: insights into neuropathy.

Muscle-driven spinal cord histological and transcriptomic alterations in a myotonic dystrophy mouse model: insights into neuropathy.

Journal: Brain communications
Published: August 22, 2024

COVID-19 related epigenetic changes and atopic dermatitis: An exploratory analysis.

COVID-19 related epigenetic changes and atopic dermatitis: An exploratory analysis.

Journal: The World Allergy Organization journal
Published: May 21, 2024
Showing 1-12 of 23

Last Updated: 09/26/2026